Experts have developed a risk score known as MIRACLE2, to predict cardiac arrest patient outcomes. This tool will help to make appropriate clinical decisions, improve selection of appropriate treatments and inform family discussion early after admission.
The study published in European Heart Journal, by a team of researchers from King's College London and King's College Hospital, details a novel risk score for heart attack centres to predict brain damage in patients who have had an out of hospital cardiac arrest.
Cardiac Arrest
Cardiac arrest occurs when the heart stops beating abruptly due to an electrical malfunction. Blood flow to vital organs is cut off causing unconsciousness.
Advertisement
‘MIRACLE2 is the first practical score which can provide objective risk assessment to help clinicians take critical decisions about invasive treatments, use of novel therapies, and standardizing care for patients without of hospital cardiac arrest (OOHCA).’
Read More..
Tweet it Now
Read More..
Out of hospital cardiac arrest (OOHCA) is a major public health challenge and can lead to considerable morbidity and mortality. Patients have an extremely high risk of long-term brain damage after cardiac arrest, but this can be difficult to predict early on after admission.
The study examined data on 400 patients who have had an out of hospital cardiac arrest and been treated at King's College Hospital and then identified characteristics of patients that developed brain injury. The team then performed prediction modelling to create a score that could be readily applied by clinicians on arrival to a heart attack centre.
![Brugada Syndrome]( "Brugada Syndrome")
Brugada syndrome is a rare genetic heart condition that affects the way electrical signals pass through the heart causing the heart to beat dangerously fast.
The MIRACLE2 predicted brain injury with high accuracy and when validating the performance of the score in nearly 500 patients from two other heart attack centres from Europe, the score performed equally well.
The risk score will now be validated in a larger number of patients and potentially across different healthcare settings, for example by ambulance staff in the community. Once the performance of the score has been checked in these settings, it could be incorporated into future clinical trials and potentially into national guidance.
Nilesh Pareek from King's College Hospital said, "MIRACLE2 is the first practical score which can provide objective risk stratification to support clinicians in making critical decisions for patients with OOHCA. This could be a major step forward in understanding which OOHCA patients to select for invasive treatments, to guide the application of novel therapies and for standardising care across all healthcare settings."
Professor Ajay Shah, BHF Professor Cardiology at King's College London and Director of the King's BHF Centre of Research Excellence, said, "People who suffer a cardiac arrest in the community are among the most serious and complex emergency patients to manage, with a wide range of possible outcomes from complete recovery to possible long-term brain damage. The new risk score developed in our study should greatly aid ambulance teams and emergency heart doctors to make early decisions about the best treatment option for each patient."
Source: Eurekalert
Brugada Syndrome
Brugada syndrome is a rare genetic heart condition that affects the way electrical signals pass through the heart causing the heart to beat dangerously fast.
Advertisement
The MIRACLE2 predicted brain injury with high accuracy and when validating the performance of the score in nearly 500 patients from two other heart attack centres from Europe, the score performed equally well.
The risk score will now be validated in a larger number of patients and potentially across different healthcare settings, for example by ambulance staff in the community. Once the performance of the score has been checked in these settings, it could be incorporated into future clinical trials and potentially into national guidance.
Nilesh Pareek from King's College Hospital said, "MIRACLE2 is the first practical score which can provide objective risk stratification to support clinicians in making critical decisions for patients with OOHCA. This could be a major step forward in understanding which OOHCA patients to select for invasive treatments, to guide the application of novel therapies and for standardising care across all healthcare settings."
Professor Ajay Shah, BHF Professor Cardiology at King's College London and Director of the King's BHF Centre of Research Excellence, said, "People who suffer a cardiac arrest in the community are among the most serious and complex emergency patients to manage, with a wide range of possible outcomes from complete recovery to possible long-term brain damage. The new risk score developed in our study should greatly aid ambulance teams and emergency heart doctors to make early decisions about the best treatment option for each patient."
Source: Eurekalert
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
 Tips to Prevent Heart AttacksHeart Attack occurs when the flow of oxygenated blood to heart muscles is hindered or stopped due to built-up of plaques in coronary arteries. Heart Attack is the No.1 killer among Indians. | Advertisement
|
Advertisement
Recommended Readings
Latest Heart Disease News
While heart failure can affect both genders, it is more commonly observed in men and is more prevalent in the elderly population.
Traumatic brain injury survivors (military, sports personnel) are at higher risk of cardiovascular and cognitive dysfunction in relative to general population.
Severe psoriasis patients are more susceptible to coronary microvascular dysfunction, which raises cardiovascular risk.
CPAP used for treating loud snoring reduces the risk of heart disease and is also a favorable alternative to weight-loss drugs in treating clogged arteries.
Consuming significant quantities of trisodium phosphate (E339) was likewise linked to a higher risk of developing coronary heart disease.
